TrialStem cell reviews and reports2020

Improvement of Pregnancy Rate and Live Birth Rate in Poor Ovarian Responders by Intraovarian Administration of Autologous Menstrual Blood Derived- Mesenchymal Stromal Cells: Phase I/II Clinical Trial.

Simin Zafardoust et al.PubMed ↗Publisher ↗

No numbers read from the abstract.